PROCEPT BioRobotics Corporation (PRCT) Revenue Growth
PROCEPT BioRobotics Corporation (PRCT) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 117.60% |
| 2023-12-31 | 81.55% |
| 2024-12-31 | 64.84% |
| 2025-12-31 | 37.22% |
How PRCT compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| KURA | Kura Oncology Inc. | 25.24% |
| MNKD | MannKind Corporation | 22.23% |
| INCY | Incyte Corporation | 21.22% |
| AXGN | Axogen Inc. | 20.21% |
| BSX | Boston Scientific Corporation | 19.87% |
These are five companies in the same sector as PRCT with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get PROCEPT BioRobotics Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("PRCT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PRCT | $20.60 | -2.23% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 |